IDE397 is a potent, selective MAT2A inhibitor developed by IDEAYA Biosciences, under clinical investigation for MTAP-deleted solid tumors. It is a leading candidate in the MAT2A research space.
Specifications
CAS: { 2439277-80-0 }
Purity: ≥{98.3%}% (HPLC)
Stock: {578kg}
MOQ: {MOQ}（sample: 1 g）
Lead time: Samples: 3–5 days; Batch: 7–21 days
Documents: COA / HPLC / NMR / MSDS (available on request)
Physicochemical Properties
| M.Wt | 340.69 | |
| Formula | C14H8ClF3N4O | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility | 10 mM in DMSO | |
| Chemical Name/SMILES | Pyrido[2,3-d]pyrimidin-2(1H)-one, 4-amino-1-(2-chlorophenyl)-7-(trifluoromethyl)- | |
As a dedicated supplier of pharmaceutical intermediates and APIs, EOS Med CDMO offers IDE397 for research and development use, We support scale-up production up to kilogram levels and provide full Drug Master File (DMF) documentation support. Every shipment comes with complete technical dossiers, including COA, MSDS, and analytical data (HPLC/HNMR), to ensure seamless regulatory compliance for your project.
Supply Capability
stock: In stock ·
Batch: up to 500 kg
Purity: 98.3%+ (HPLC) ·
Specifications
Synonyms: IDE-397
Target: MAT2A
Research Area: MTAP-deleted cancers
Transportation Conditions: This product is a non-hazardous chemical and should be transported at room temperature. It can be stably stored for several weeks during normal transportation and customs clearance.
Storage Conditions: Short-term (days to weeks) storage at 0-4°C; long-term (months to years) storage at -20°C.
Solubility: To be determined.
Shelf Life: Over 2 years under proper storage conditions.
Pharmaceutical Preparations: To be determined.
HS Code: 2934.99.9001